Substance / Medication

Econazole nitrate

Overview

Clinical overview including description, indications, and evidence base is pending physician authorship or FDA SPL integration. Graph-derived relationship data is available below.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
Treatment of Signs and Symptoms (Pruritus) of Interdigital Tinea Pedis With Econazole Nitrate Foam, 1.
Hoffman Lauren K, Raymond Isabelle, Kircik Leon · J Drugs Dermatol · 2018
PMID: 29462232Observational
Evaluation of solid lipid microparticles produced by spray congealing for topical application of econazole nitrate.
Passerini Nadia, Gavini Elisabetta, Albertini Beatrice et al. · J Pharm Pharmacol · 2009
PMID: 19405993Observational
Solid lipid nanoparticles (SLN) as carriers for the topical delivery of econazole nitrate: in-vitro characterization, ex-vivo and in-vivo studies.
Sanna Vanna, Gavini Elisabetta, Cossu Massimo et al. · J Pharm Pharmacol · 2007
PMID: 17725847Observational
Evaluation of in vitro activity of ciclopirox olamine, butenafine HCl and econazole nitrate against dermatophytes, yeasts and bacteria.
Kokjohn Katrina, Bradley Mary, Griffiths Brian et al. · Int J Dermatol · 2003
PMID: 12895182Observational
Antifungal Nail Lacquer for Enhanced Transungual Delivery of Econazole Nitrate.
Puri Vinam, Savla Riya, Chen Kevin et al. · Pharmaceutics · 2022
PMID: 36297639OtherFull text (PMC)
Formulation Development, In Vitro and In Vivo Evaluation of Topical Hydrogel Formulation of Econazole Nitrate-Loaded β-Cyclodextrin Nanosponges.
Srivastava Shivansh, Mahor Alok, Singh Gyanendra et al. · J Pharm Sci · 2021
PMID: 34293406Preclinical

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Econazole nitrate (substance)
SNOMED CT
73827006
UMLS CUI
C0546862

Clinical Data

This intervention maps to 4 entities in the Ltrl knowledge graph.

4
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.